Stadler, Z. K., Maio, A., Chakravarty, D., Kemel, Y., Sheehan, M., Salo-Mullen, E., Tkachuk, K., Fong, C. J., Nguyen, B., Erakky, A., Cadoo, K., Liu, Y., Carlo, M. I., Latham, A., Zhang, H., Kundra, R., Smith, S., Galle, J., Aghajanian, C., Abu-Rustum, N., Varghese, A., O'Reilly, E. M., Morris, M., Abida, W., Walsh, M., Drilon, A., Jayakumaran, G., Zehir, A., Ladanyi, M., Ceyhan-Birsoy, O., Solit, D. B., Schultz, N., Berger, M. F., Mandelker, D., Diaz, L. A., Offit, K., & Robson, M. E. (2021). therapeutic Implications of Germline Testing in Patients With Advanced Cancers. Journal of clinical oncology, 39(24), 2698–2709. http://access.bl.uk/ark:/81055/vdc_100150610394.0x00003c